This company has been marked as potentially delisted and may not be actively trading. NYSE:GEN Genesis Healthcare (GEN) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsCompetitorsDividendEarningsHeadlinesInsider TradesOptions ChainOwnershipTrendsBuy This Stock About Genesis Healthcare Stock (NYSE:GEN) 30 days 90 days 365 days Advanced Chart Get Genesis Healthcare alerts:Sign Up Key Stats Today's Range$25.44▼$25.9750-Day Range$0.18▼$0.6052-Week Range$0.40▼$1.37Volume3.74 million shsAverage Volume4.10 million shsMarket Capitalization$16.47 billionP/E Ratio28.63Dividend Yield1.94%Price Target$31.50Consensus RatingModerate Buy Company OverviewGenesis Healthcare, Inc., together with its subsidiaries, owns and operates skilled nursing facilities and assisted/senior living facilities in the United States. The company operates through three segments: Inpatient Services; Rehabilitation Therapy Services; and Other Services. It also provides a range of rehabilitation therapy services, including speech-language pathology, physical therapy, occupational therapy, and respiratory therapy. In addition, the company offers other specialty medical services, such as physician, staffing, and other healthcare related services. As of December 31, 2020, it provided inpatient services through a network of approximately 341 skilled nursing facilities and assisted/senior living communities in 24 states; and supplied rehabilitation and respiratory therapy to approximately 1,400 healthcare locations in 42 states, the District of Columbia and China. The company was formerly known as FC-GEN Operations Investment, LLC and changed its name to Genesis HealthCare, Inc. in February 2015. Genesis HealthCare, Inc. was founded in 2003 and is headquartered in Kennett Square, Pennsylvania.Read More… Genesis Healthcare Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks31st Percentile Overall ScoreGEN MarketRank™: Genesis Healthcare scored higher than 31% of companies evaluated by MarketBeat, and ranked 261st out of 321 stocks in the business services sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.3 / 5Analyst RatingModerate Buy Consensus RatingGenesis Healthcare has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 3 buy ratings, 3 hold ratings, and no sell ratings.Amount of Analyst CoverageGenesis Healthcare has received no research coverage in the past 90 days.Read more about Genesis Healthcare's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings Growth5.52% Earnings GrowthEarnings for Genesis Healthcare are expected to grow by 5.52% in the coming year, from $1.63 to $1.72 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Genesis Healthcare is 28.63, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 22.00.Price to Earnings Ratio vs. SectorThe P/E ratio of Genesis Healthcare is 28.63, which means that it is trading at a less expensive P/E ratio than the Business Services sector average P/E ratio of about 31.00. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for GEN. Dividend2.5 / 5Dividend StrengthModerate Dividend YieldGenesis Healthcare pays a meaningful dividend of 3.05%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthGenesis Healthcare does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Genesis Healthcare is 55.56%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Genesis Healthcare will have a dividend payout ratio of 29.07% next year. This indicates that Genesis Healthcare will be able to sustain or increase its dividend.Read more about Genesis Healthcare's dividend. Sustainability and ESGN/AEnvironmental ScoreN/A Short InterestThere is no current short interest data available for GEN. News and Social Media0.6 / 5News Sentiment0.00 News Coverage This WeekMarketBeat has tracked 2 news articles for Genesis Healthcare this week, compared to 3 articles on an average week.Search Interest9 people have searched for GEN on MarketBeat in the last 30 days. This is an increase of 125% compared to the previous 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Genesis Healthcare insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 3.30% of the stock of Genesis Healthcare is held by insiders.Percentage Held by Institutions82.08% of the stock of Genesis Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Genesis Healthcare's insider trading history. Receive GEN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Genesis Healthcare and its competitors with MarketBeat's FREE daily newsletter. Email Address GEN Stock News HeadlinesQ1 2025 Omega Healthcare Investors Inc Earnings CallMay 3 at 4:35 AM | finance.yahoo.comOmega healthcare raises 2025 AFFO guidance to $2.95-$3.01 per shareMay 2, 2025 | msn.comTrump’s Bitcoin Reserve is No Accident…Crypto policy is changing fast… Smart investors are positioning themselves to benefit. And it's all happening outside of the traditional system. At the center of it all is one crypto project we believe could be the #1 coin to own right now.May 6, 2025 | Crypto 101 Media (Ad)Genesis unveils precision lung cancer surgery with robotic bronchoscopyApril 21, 2025 | msn.comMon Health files building permit with City of Bridgeport for new $26.5M hospitalApril 3, 2025 | msn.comMercyOne Genesis Silvis Medical Center put on precautionary lockdownApril 3, 2025 | msn.comLifeServe and MercyOne Genesis, Davenport, announce partnershipMarch 29, 2025 | msn.comMilitary families face four key health care deadlines by March 31March 13, 2025 | msn.comSee More Headlines GEN Stock Analysis - Frequently Asked Questions How were Genesis Healthcare's earnings last quarter? Genesis Healthcare, Inc. (NYSE:GEN) announced its quarterly earnings data on Thursday, August, 1st. The company reported $0.53 EPS for the quarter, meeting the consensus estimate of $0.53. The company's revenue was up 2.3% on a year-over-year basis. Is Genesis Healthcare doing a stock buyback? Genesis Healthcare's board authorized a stock buyback plan on Thursday, May 9th 2024, which allows the company to buy back $3,000,000,000 in shares, according to EventVestor. This means that the company could purchase up to 23.1% of its stock through open market purchases. Stock repurchase plans are typically an indication that the company's board believes its shares are undervalued. What other stocks do shareholders of Genesis Healthcare own? Based on aggregate information from My MarketBeat watchlists, some other companies that Genesis Healthcare investors own include Invesco QQQ (QQQ), NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Advanced Micro Devices (AMD), Adobe (ADBE) and CrowdStrike (CRWD). Company Calendar Last Earnings8/01/2024Ex-Dividend for 3/12 Dividend2/14/2025Record date for 3/12 Dividend2/17/2025Dividend Payable3/12/2025Today5/06/2025Fiscal Year End3/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorBusiness Services Industry Prepackaged software Sub-IndustryN/A Current SymbolNYSE:GEN Previous SymbolNYSE:SKH CIK849399 Webwww.genesishcc.com Phone610-444-6350Fax302-636-5454Employees2,700Year FoundedN/APrice Target and Rating Average Stock Price Target$31.50 High Stock Price Target$37.00 Low Stock Price Target$27.00 Potential Upside/Downside+22.2%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage6 Analysts Profitability EPS (Most Recent Fiscal Year)$0.90 Trailing P/E Ratio28.63 Forward P/E Ratio15.81 P/E GrowthN/ANet Income$836 million Net Margins17.83% Pretax Margin23.69% Return on Equity155.48% Return on Assets9.12% Debt Debt-to-Equity Ratio7.50 Current Ratio0.48 Quick Ratio0.48 Sales & Book Value Annual Sales$2.80 billion Price / Sales5.89 Cash Flow$3.06 per share Price / Cash Flow8.42 Book Value($0.16) per share Price / Book-161.06Miscellaneous Outstanding Shares639,130,000Free Float618,038,000Market Cap$16.47 billion OptionableOptionable Beta0.84 10 Stocks Set to Soar in Spring 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free Report This page (NYSE:GEN) was last updated on 5/6/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredTrump’s Bitcoin Reserve is No Accident…Crypto policy is changing fast… Smart investors are positioning themselves to benefit. And it's all happeni...Crypto 101 Media | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genesis Healthcare, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Genesis Healthcare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.